Replies to post #270091 on Avid Bioservices Inc (CDMO)

[biopharm]

I am hoping for surprise liver data re: PS Targeting ....since the liver performs over 500 different chemical functions...

PS targeting and watching the relevant predictive protein pathways will rule out many already FDA approved drugs ( which the FDA should request retests on the MOA ...) but likely, they will all be mostly replaced one by one with PS targeting drugs